SCHEMBL17343389

SCHEMBL17343389

c1ccc(-c2cc(-c3ccccc3)cc(-c3cc(-c4ccccc4)nc(-c4ccccc4)c3)c2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.63
MEN1 O00255 6/20 0.59
KMT2A Q03164 6/20 0.59
RAB9A P51151 1/20 0.59
ADORA1 P30542 3/20 0.56
ALDH1A1 P00352 3/20 0.56
ADORA2A P29274 2/20 0.56
HPGD P15428 2/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
GABRA1 P14867 1/20 0.52
GABRG2 P18507 1/20 0.52
GABRB3 P28472 1/20 0.52
GABRA5 P31644 1/20 0.52
GABRA3 P34903 1/20 0.52
ADORA3 P0DMS8 1/20 0.52
ADORA2B P29275 1/20 0.52
MAPT P10636 3/20 0.50
MCL1 Q07820 2/20 0.50
AGTR1 P30556 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14425567 1.00 CYP19A1 (0.63) CYP19A1MEN1KMT2ARAB9AADORA1
SCHEMBL12258336 1.00 CYP19A1 (0.63) CYP19A1MEN1KMT2ARAB9AADORA1
SCHEMBL13203192 1.00 CYP19A1 (0.63) CYP19A1MEN1KMT2ARAB9AADORA1
SCHEMBL13203187 1.00 CYP19A1 (0.63) CYP19A1MEN1KMT2ARAB9AADORA1
SCHEMBL14425876 0.97 CYP19A1 (0.61) CYP19A1MEN1KMT2ARAB9AADORA1
SCHEMBL13203061 0.97 CYP19A1 (0.61) CYP19A1MEN1KMT2ARAB9AADORA1
SCHEMBL13203170 0.97 CYP19A1 (0.61) CYP19A1MEN1KMT2ARAB9AADORA1
SCHEMBL22214903 0.97 CYP19A1 (0.61) CYP19A1MEN1KMT2ARAB9AADORA1
SCHEMBL14425864 0.97 CYP19A1 (0.61) CYP19A1MEN1KMT2ARAB9AADORA1
SCHEMBL13916912 0.97 CYP19A1 (0.61) CYP19A1MEN1KMT2ARAB9AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11329230-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2022-05-10 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed
US-20170179402-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed
US-20170179402-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed
US-9680108-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-13 US disclosed
US-9680108-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-13 US disclosed
US-20160218297-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2016-07-28 US disclosed
US-20160020404-A1 ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-01-21 US disclosed
US-20160020404-A1 ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-01-21 US disclosed
US-20150364693-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-17 US disclosed
US-20150364693-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11329230-B2 Organic light-emitting device EML4, SUN2, TRPA1 CYP19A1 1341/4885MEN1 2816/4885KMT2A 1971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.